Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)-Reference-Cited by-同舟云学术

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Published:2012-06 Issue:6 Volume:30 Page:283-293
ISSN:0213-005X
Container-title:Enfermedades Infecciosas y Microbiología Clínica
language:es
Short-container-title:Enfermedades Infecciosas y Microbiología Clínica

Author:

Blasco Antonio Javier,Arribas José Ramón,Boix Vicente,Clotet Bonaventura,Domingo Pere,González-García Juan,Knobel Hernando,López Juan Carlos,Llibre Josep M.,Lozano Fernando,Miró José M.,Podzamczer Daniel,Santamaría Juan Miguel,Tuset Montserrat,Zamora Laura,Lázaro Pablo,Gatell Josep M.

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference43 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N Engl J Med,1998

2. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Gro up;Mocroft;Lancet,1998

3. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease;Autran;Science,1997

4. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir;Kelleher;J Infect Dis,1996

5. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection;Lok;AIDS,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades Infecciosas y Microbiología Clínica;2018-05

2. Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades infecciosas y microbiologia clinica (English ed.);2018-05

3. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades Infecciosas y Microbiología Clínica;2017-02

4. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades infecciosas y microbiologia clinica (English ed.);2017-02

5. Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults;Enfermedades Infecciosas y Microbiología Clínica;2016-06